98 Views | 47 Downloads
Correspondence: Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA, Tel: 212-639-5851, Fax: 929-321-5023, kantoff@mskcc.org
Author contributions: Conception and design: Y.Z. Mazzu, P.W. Kantoff. Development of methodology: Y.Z. Mazzu.
Acquisition of data (provided animals, acquired and managed patient cohort data, provided facilities, etc.): Y.Z. Mazzu, J. Armenia, G. Chakraborty, Y. Yoshikawa, S.A. Coggins, S. Nandakumar, T.A. Gerke, M.M. Pomerantz, X. Qiu, H. Zhao, M. Atiq, N. Khan, K. Komura, G.M. Lee, S.W. Fine, C. Bell, E. O’Connor, H.W. Long, M.L. Freedman, B. Kim, P.W. Kantoff
Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): Y.Z. Mazzu, J. Armenia, S. Nandakumar, T.A. Gerke, M.M. Pomerantz, P.W. Kantoff. Writing, review, and/or revision of the manuscript: Y.Z. Mazzu, J. Armenia, S. Nandakumar, M.M. Pomerantz, P.W. Kantoff.
Administrative, technical, or material support (i.e., reporting or organizing data): Y.Z. Mazzu, J. Armenia, G. Chakraborty, Y. Yoshikawa, S.A. Coggins, S. Nandakumar, M.M. Pomerantz. Study supervision: P.W. Kantoff.
Disclosures: As of February 18, 2019, P.W. Kantoff reports the following disclosures for the last 36-month period: he has investment interest in Context Therapeutics LLC, DRGT, Placon, Seer Biosciences, and Tarveda Therapeutics; he is a company board member for Context Therapeutics LLC; he is a consultant/scientific advisory board member for BIND Biosciences, Inc.,
Bavarian Nordic Immunotherapeutics, DRGT, GE Healthcare, Janssen, Metamark, New England Research Institutes, Inc., OncoCellMDX, Progenity, Sanofi, Seer Biosciences, Tarveda Therapeutics, and Thermo Fisher; and he serves on data safety monitoring boards for Genentech/Roche and Merck.
J. Armenia is currently an employee of AstraZeneca, but was not when he performed this work. All other authors declare no potential conflicts of interest.
This research was funded in part through the NIH/NCI Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center (P30 CA008748) and dNTP assays were funded in part through NIH/NIGMS R01 GM104198 to B. Kim and NIH/NIAID R01 AI136581 to B. Kim.
© 2019 American Association for Cancer Research.